NME1 and colorectal carcinoma: Exosomal delivery of PGM5‐AS1 and oxaliplatin restored oxaliplatin sensitivity in resistant CRC cells by promoting apoptosis, downregulating progestagen associated endometrial protein (PAEP), and upregulating NME1.